Concord Healthcare Group Co., Ltd. (Stock Code: 2453) has issued a notice convening an Extraordinary General Meeting on December 5, 2025, in Beijing. The primary resolution involves abolishing the existing Supervisory Committee, transferring its functions to the Board’s Audit Committee, and amending its Articles of Association, the Procedural Rules for Shareholders’ Meetings, and the Procedural Rules for Meetings of the Board.

The proposed changes are presented as a special resolution for shareholders’ consideration. The company indicates that the adjustments are intended to align with updated requirements in laws, regulations, and related guidelines. Subject to approval, the referenced corporate governance documents will be revised accordingly.

According to the notice, the record date for determining voting eligibility is December 5, 2025. Shareholders who wish to attend and vote must complete necessary procedures before the specified deadlines. The company emphasizes that no formal action will be taken concerning the merger, division, or dissolution in this issuance, focusing solely on the Supervisory Committee’s abolition and related document updates.

The official announcement reminds shareholders to submit written proxies if they are unable to attend in person. Full details of the meeting agenda and drafting revisions are available on the company’s designated information platforms.